For the year ending 2025-12-31, HROW made $272,303K in revenue. -$5,139K in net income. Net profit margin of -1.89%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 272,303 | 199,614 | ||
| Cost of sales | 67,934 | 49,245 | ||
| Gross profit | 204,369 | 150,369 | ||
| Selling, general and administrative | 152,914 | 129,064 | ||
| Research and development | 20,940 | 12,230 | ||
| Impairment of long-lived assets | - | 253 | ||
| Total operating expenses | 173,854 | 141,547 | ||
| Income from operations | 30,515 | 8,822 | ||
| Interest expense, net | 24,180 | 22,786 | ||
| Loss on extinguishment of debt | -7,750 | - | ||
| Investment (loss) gain from eton pharmaceuticals | - | -3,171 | ||
| Other income (expense), net | 47 | -185 | ||
| Total other expense, net | -31,883 | -26,142 | ||
| Loss before income taxes | -1,368 | -17,320 | ||
| Income tax expense | 3,771 | 161 | ||
| Net loss | -5,139 | -17,481 | ||
| Basic EPS | -0.14 | -0.49 | ||
| Diluted EPS | -0.14 | -0.49 | ||
| Basic Average Shares | 36,760,461 | 35,650,714 | ||
| Diluted Average Shares | 36,760,461 | 35,650,714 | ||
HARROW, INC. (HROW)
HARROW, INC. (HROW)